Contribute Try STAT+ Today

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is still evolving, but for now, we hope to tend to some sundry chores, catch up on our napping, and hang with a short person or two. And what about you? This may be a good opportunity to take in a moving picture or peruse the inventory in your local library. You could catch up with someone special. Or perhaps this is a good time to finish your taxes, since the Treasury could use the funds to cover golf outings. Well, whatever you do, have a grand time. But be safe. Enjoy, and see you soon.

Canada is considering significant changes to how it will apply new regulations aimed at lowering costs, as unhappy drug makers delay product launches and blame it for job cuts, Reuters reports. In August, the government passed new regulations for patented drugs despite lobbying from drug makers. The rules base Canadian prices on those from a group of countries with lower prices than a benchmark group now used to set ceilings, and give regulators the power to review new medicines based on cost-effectiveness.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.